Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials

Low Cancer Stem Cell Marker Expression and Low Hypoxia Identify Good Prognosis Subgroups in HPV(-) HNSCC after Postoperative Radiochemotherapy: A Multicenter Study of the DKTK-ROG

(2016) A. Linge et al.   CLINICAL CANCER RESEARCH

Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma

(2016) Bouchra Tawk et al.   RADIOTHERAPY AND ONCOLOGY

Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study

(2015) Jens Bentzen et al.   ACTA ONCOLOGICA

Gene Expression Signatures as Biomarkers of Tumour Hypoxia

(2015) B.H.L. Harris et al.   CLINICAL ONCOLOGY

Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival

(2015) Michel C. van Harten et al.   ORAL ONCOLOGY

IAEA-HypoX. A randomized multicenter study of the hypoxic radiosensitizer nimorazole concomitant with accelerated radiotherapy in head and neck squamous cell carcinoma

(2015) Mohamed A. Hassan Metwally et al.   RADIOTHERAPY AND ONCOLOGY

NIMRAD – A Phase III Trial to Investigate the Use of Nimorazole Hypoxia Modification with Intensity-modulated Radiotherapy in Head and Neck Cancer

(2014) D. Thomson et al.   CLINICAL ONCOLOGY

Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer

(2014) Pernille Lassen et al.   RADIOTHERAPY AND ONCOLOGY

A 26-Gene Hypoxia Signature Predicts Benefit from Hypoxia-Modifying Therapy in Laryngeal Cancer but Not Bladder Cancer

(2013) A. Eustace et al.   CLINICAL CANCER RESEARCH

Identification of accurate reference genes for RT-qPCR analysis of formalin-fixed paraffin-embedded tissue from primary Non-Small Cell Lung Cancers and brain and lymph node metastases

(2013) Signe Søes et al.   LUNG CANCER

Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells

(2013) Brita Singers Sørensen et al.   RADIOTHERAPY AND ONCOLOGY

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma

(2012) Guy N.J. Betts et al.   EUROPEAN JOURNAL OF CANCER

Imaging hypoxia to improve radiotherapy outcome

(2012) Michael R. Horsman et al.   Nature Reviews Clinical Oncology

FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: Results from the DAHANCA 24 trial

(2012) Lise Saksø Mortensen et al.   RADIOTHERAPY AND ONCOLOGY

Hypoxia Gene Expression Signatures as Prognostic and Predictive Markers in Head and Neck Radiotherapy

(2012) Kasper Toustrup et al.   SEMINARS IN RADIATION ONCOLOGY

Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer

(2011) K. Toustrup et al.   CANCER RESEARCH

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): A comprehensive analysis by tumour site

(2011) Pierre Blanchard et al.   RADIOTHERAPY AND ONCOLOGY

Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis

(2011) Jens Overgaard   RADIOTHERAPY AND ONCOLOGY

Gene expression classifier predicts for hypoxic modification of radiotherapy with nimorazole in squamous cell carcinomas of the head and neck

(2011) Kasper Toustrup et al.   RADIOTHERAPY AND ONCOLOGY

Identifying pH independent hypoxia induced genes in human squamous cell carcinomasin vitro

(2010) Brita Singers Sørensen et al.   ACTA ONCOLOGICA

The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome

(2010) Pernille Lassen   RADIOTHERAPY AND ONCOLOGY

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer

(2009) Pernille Lassen et al.   RADIOTHERAPY AND ONCOLOGY